Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR) (AA 20-764) antibody
| Antigen | Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR) |
| Synonyms | Flk1, Ly73, Flk-1, Krd-1, VEGFR2, VEGFR-2, sVEGFR-2, 6130401C07, FLK1, CD309, VEGFR, Vegfr-2, MGC93590, KDR, FLK-1, flk-1, vegfr-2 |
| Binding Site |
Alternatives AA 20-764 |
| Clonality | Monoclonal (4B4) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives ELISA, Immunofluorescence (IF), Flow Cytometry (FACS), Western Blotting (WB) |
![]() |
1 reference available |
| Catalog no. | ABIN969231 |
| Quantity | 0.1ml |
| Price | 363.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 3 to 4 Business Days |
Additional Information
| Alternative name | KDR |
| Gene ID | 3791 |
| Immunogen | Purified recombinant extracellular fragment of human KDR (AA 20-764) fused with hIgGFc tag expressed in HEK293 cells. |
| Format | Liquid |
| Isotype | IgG1 |
| Clone | 4B4 |
| Description |
KDR has also been designated as VEFR-2 (Vascular endothelial growth factor receptor 2), CD309 (cluster of differentiation 309) and Flk1 (fetal liver kinase 1). Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. KDR is one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc. Mutations of this gene are implicated in infantile capillary hemangiomas. Synonyms: FLK1, CD309, VEGFR, VEGFR2 |
| Molecular Weight | 152kDa |
Application Details
| Application Notes |
Western Blotting: 1/500 - 1/2000. Immunofluorescence: 1/200 - 1/1000. Flow cytometry: 1/200 - 1/400. ELISA: Propose dilution 1/10000. Not yet tested in other applications. Determining optimal working dilutions by titration test. |
| Purification | Ascites |
| Buffer | Ascitic fluid containing 0.03% sodium azide. |
| Preservative | 0.03% sodium azide |
| Storage | Store at 4℃, for long term storage, store at -20℃. |
| Restrictions | For Research Use only |
Publications
| Product |
Lee, Bone, Strege et al.: "VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia." in: Blood, Vol. 104, Issue 3, pp. 788-94, 2004 (PubMed).
|
Alternatives
Alternatives for antigen "Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR)", type "Antibodies"




Alternatives